Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
Clinical trial NCT00722488 · COMPLETED
Trial details
- NCT number
- NCT00722488
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2013-07-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.